跳至主要内容
临床试验/NCT01797705
NCT01797705已完成不适用

Revised Algorithm for Next Generation DeVilbiss AutoAdjust CPAP

DeVilbiss Healthcare LLC2 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
33
试验地点
2
主要终点
% Agreement Between Reviewer and Machine Pressure Settings During Sleep Study

研究概览

简要总结

The purpose of this protocol is to improve the current FDA-approved continuous positive pressure auto-titration algorithm, including treatment precision, residual disease detection characteristics and phenotyping with the DeVilbiss brand AutoAdjust CPAP device.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Apnea hypopnea index ≥ 15 / hour of sleep on the diagnostic polysomnogram, or diagnostic component of a split night polysomnogram
  • Sleep efficiency reported on CPAP titration night PSG should be > 78%
  • Diagnosis of moderate to severe obstructive sleep apnea (AHI ≥15) or central/complex sleep apnea
  • On stable CPAP or APAP [Automatic Positive Airway Pressure] therapy, with compliant use averaging 4 or more hours nightly
  • Age 21-75 years
  • Predominately central sleep apnea for up to 10 subjects only
  • Willingness to give written informed consent and ability to adhere to visit schedule

排除标准

  • Diagnosis of mild sleep apnea
  • CPAP naïve patients
  • Co-morbid conditions which render participation to be at risk. These may include patients with congestive heart failure, COPD [Chronic Obstructive Pulmonary Disease] or psychiatric illness
  • Allergies to mask materials
  • Evidence of another primary sleep disorder
  • Evidence of arousing periodic limb movements during titration
  • Contraindications as listed on product labeling
  • Currently diagnosed with depression if symptomatic
  • Deemed medically unsuitable by investigator
  • Evidence of any type of infection or treatment of an infectious condition during the period of research participation
  • Have a bi-level requirement, or prescribed a bi-level therapy device
  • CPAP pressure >15cmH2O
  • Subjects with tracheotomy
  • Uncontrolled hypertension
  • Require supplemental oxygen
  • Stimulants, major tranquillizers or antipsychotics
  • Restless Leg Syndrome or Periodic Leg Movement Index of > 5 per hour

结局指标

主要结局

% Agreement Between Reviewer and Machine Pressure Settings During Sleep Study

时间窗: 1 night

The primary objective for the study was demonstrating effectiveness of therapy provided by the DeVilbiss AutoAdjust device as reported by the expert human reviewer. The primary endpoint was that expert human reviewer should agree with pressure changes made by the machine during each 20-minute epoch at least 80% of the time. Expert human reviewer reviewed each study and made a determination at 20-minute time points, in context of REM/NON-REM sleep and supine/non-supine positions, marking the machine pressure response with an "agree" or "disagree." Pressure changes might show no change, increase or decrease during the 20-minute epoch.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验